DK3810587T3 - Substituerede alkoxypyridinylindolsulfonamider - Google Patents

Substituerede alkoxypyridinylindolsulfonamider Download PDF

Info

Publication number
DK3810587T3
DK3810587T3 DK19731283.8T DK19731283T DK3810587T3 DK 3810587 T3 DK3810587 T3 DK 3810587T3 DK 19731283 T DK19731283 T DK 19731283T DK 3810587 T3 DK3810587 T3 DK 3810587T3
Authority
DK
Denmark
Prior art keywords
alkoxypyridinylindolesulfonamides
substituted
substituted alkoxypyridinylindolesulfonamides
Prior art date
Application number
DK19731283.8T
Other languages
English (en)
Inventor
Cécile Pegurier
Laurent Provins
Emre M Isin
Marie Ledecq
Original Assignee
Ucb Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Pharma Gmbh filed Critical Ucb Pharma Gmbh
Application granted granted Critical
Publication of DK3810587T3 publication Critical patent/DK3810587T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DK19731283.8T 2018-06-20 2019-06-19 Substituerede alkoxypyridinylindolsulfonamider DK3810587T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18178773.0A EP3584244A1 (en) 2018-06-20 2018-06-20 Substituted alkoxypyridinyl indolsulfonamides
PCT/EP2019/066148 WO2019243398A1 (en) 2018-06-20 2019-06-19 Substituted alkoxypyridinyl indolsulfonamides

Publications (1)

Publication Number Publication Date
DK3810587T3 true DK3810587T3 (da) 2022-10-31

Family

ID=62715911

Family Applications (1)

Application Number Title Priority Date Filing Date
DK19731283.8T DK3810587T3 (da) 2018-06-20 2019-06-19 Substituerede alkoxypyridinylindolsulfonamider

Country Status (14)

Country Link
US (1) US11976056B2 (da)
EP (3) EP3584244A1 (da)
JP (1) JP7371031B2 (da)
CN (1) CN112292375B (da)
CA (1) CA3101086A1 (da)
DK (1) DK3810587T3 (da)
ES (1) ES2929829T3 (da)
HR (1) HRP20221289T1 (da)
HU (1) HUE060181T2 (da)
LT (1) LT3810587T (da)
MX (1) MX2020012823A (da)
PL (1) PL3810587T3 (da)
PT (1) PT3810587T (da)
WO (1) WO2019243398A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020254289A1 (en) * 2019-06-17 2020-12-24 Ucb Pharma Gmbh N-(phenyl)-indole-3-sulfonamide derivatives and related compounds as gpr17 modulators for treating cns disorders such as multiple sclerosis
US20230167406A1 (en) * 2020-05-01 2023-06-01 The Children's Medical Center Corporation Compositions and methods of promoting myelination
CN112375027B (zh) * 2020-12-07 2023-03-31 中国药科大学 吲哚磺酰胺类衍生物及其医药用途
JP2024507176A (ja) * 2021-02-26 2024-02-16 エフ. ホフマン-ラ ロシュ アーゲー 新規なピリミジン-2-イルスルホンアミド誘導体
WO2023241960A1 (en) * 2022-06-15 2023-12-21 Basf Se A process for the photolytic chlorination of 3-halopyridine with molecular chlorine
EP4311828A1 (en) * 2022-07-26 2024-01-31 Basf Se A process for the photolytic chlorination of 3-halopyridine with molecular chlorine
JP2025523939A (ja) * 2022-07-20 2025-07-25 エフ. ホフマン-ラ ロシュ アーゲー 新規のナフチルおよびイソキノリンスルホンアミド誘導体
WO2024017857A1 (en) 2022-07-20 2024-01-25 F. Hoffmann-La Roche Ag Novel imidazopyridine and pyrazolopyridine sulfonamide derivatives
EP4558496A1 (en) * 2022-07-20 2025-05-28 F. Hoffmann-La Roche AG Novel pyrimidinyl and triazinyl sulfonamide derivatives
US20260028335A1 (en) * 2022-07-20 2026-01-29 Hoffmann-La Roche Inc. Novel isothiazol-3-yl and isoxazol-3-yl sulfonamide compounds
CN119546576A (zh) 2022-07-20 2025-02-28 豪夫迈·罗氏有限公司 新颖的异喹啉酮、吡咯并吡啶酮和噻吩并吡啶酮磺酰胺衍生物
EP4562003A1 (en) * 2022-07-28 2025-06-04 F. Hoffmann-La Roche AG Novel 7-substituted indole sulfonamide derivatives
MA71601A (fr) * 2022-07-28 2025-05-30 F. Hoffmann-La Roche Ag Nouveaux dérivés d'indole sulfonamide substitués en position 7
CR20250058A (es) * 2022-08-26 2025-05-09 Hoffmann La Roche Derivados novedosos deuterados de pirimidin-2-il sulfonamida
AR131263A1 (es) * 2022-12-02 2025-03-05 Rewind Therapeutics Nv Compuestos de pirrolil-sulfonamida fusionados
WO2024153233A1 (en) * 2023-01-19 2024-07-25 Nanjing Immunophage Biotech Co., Ltd Compounds and their uses as gpr17 antagonists
GB2700773A (en) * 2024-05-23 2026-03-11 Pheno Therapeutics Ltd Compounds
GB2701173A (en) 2024-05-23 2026-04-22 Pheno Therapeutics Ltd Compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814084B4 (de) 1998-03-30 2005-12-22 Lts Lohmann Therapie-Systeme Ag D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung
SE9904750D0 (sv) 1999-12-23 1999-12-23 Pharmacia & Upjohn Ab New formulation, use and method
DE602005024537D1 (de) 2004-04-27 2010-12-16 Takeda Pharmaceutical Neuer ligand eines g-protein-konjugierten rezeptorproteins und verwendung davon
ITMI20042007A1 (it) 2004-10-21 2005-01-21 Consiglio Nazionale Ricerche "modulatori del ricettore gpr17 e loro impieghi terapeutici"
CA2633588A1 (en) 2005-12-20 2007-08-23 Teikoku Pharma Usa, Inc. Methods of transdermally administering an indole serotonin receptor agonist and transdermal compositions for use in the same
WO2009000262A1 (de) 2007-06-25 2008-12-31 Acino Ag Elektrophoretisches transdermales applikationssystem
AU2009313315A1 (en) * 2008-11-07 2011-06-30 The Cleveland Clinic Foundation Compounds and methods of promoting oligodendrocyte precursor differentiation
GB2491520A (en) 2010-03-11 2012-12-05 Jerry Swinford Method and apparatus for washing downhole tubulars and equipment
EP2567698B1 (en) * 2011-09-07 2014-02-12 Rheinische Friedrich-Wilhelms-Universität Bonn GPR 17 agonists and screening assay
KR20150008468A (ko) 2012-05-09 2015-01-22 폰다지오네 이탈리아나 스클레로시 멀티플라 - 에프아이에스엠 온러스 Gpr17 수용체 조절제
JP7044789B2 (ja) 2016-09-24 2022-03-30 ワシントン・ユニバーシティ Sarm1 nadアーゼ活性の阻害剤およびその使用
TWI754702B (zh) 2016-12-28 2022-02-11 德商Ucb製藥有限公司 (氮雜)吲哚-和苯並呋喃-3-磺醯胺類

Also Published As

Publication number Publication date
WO2019243398A1 (en) 2019-12-26
CA3101086A1 (en) 2019-12-26
JP2021527696A (ja) 2021-10-14
HUE060181T2 (hu) 2023-02-28
JP7371031B2 (ja) 2023-10-30
US11976056B2 (en) 2024-05-07
CN112292375B (zh) 2023-12-05
CN112292375A (zh) 2021-01-29
EP3810587B1 (en) 2022-08-10
US20210214337A1 (en) 2021-07-15
MX2020012823A (es) 2021-02-15
ES2929829T3 (es) 2022-12-01
EP4086248A1 (en) 2022-11-09
EP3810587A1 (en) 2021-04-28
LT3810587T (lt) 2022-11-25
HRP20221289T1 (hr) 2022-12-23
PL3810587T3 (pl) 2023-02-06
EP3584244A1 (en) 2019-12-25
PT3810587T (pt) 2022-11-14

Similar Documents

Publication Publication Date Title
FIC20253006I1 (fi) Linvoseltamabi
FIC20260010I1 (fi) imlunestrantti
EP3890716A4 (en) COMBINATION THERAPIES
EP3846674C0 (en) VAGINAL SPECULUM
EP3849534A4 (en) COMBINATION THERAPIES
EP3555124C0 (en) TCR NYESO
DK3810587T3 (da) Substituerede alkoxypyridinylindolsulfonamider
EP3781060A4 (en) CRYOPROBE
EP3784463A4 (en) Fluorosulfones
EP3872558A4 (en) OPTICAL ISOLATOR
EP3810860C0 (en) COUPLER
EP3792200A4 (en) TANK TANK
EP3745904C0 (de) Stockgriff
EP3878374A4 (en) Occlusion device
EP3721129C0 (en) Cryosphere
EP3844177A4 (en) COMBINATION THERAPIES
DK3587968T3 (da) Fluidsystem
EP3773733A4 (en) METALLO-LIOTHYRONINE
DK3752258T3 (da) Trampolin
EP3787554A4 (en) STENT TRANSPLANT
EP3738602A4 (en) CYTOCIDE
ES1207586Y (es) Furgo-caravana
EP3787995C0 (en) HARNESS SADDLE
MA49925A (fr) Claie
EP3767002A4 (en) PUNCH THORN